Stablepharma

Bath, United Kingdom · Founded 2012 · Privately Held (backing)

Developer of a thermostability technology designed to improve the stability and accessibility of temperature-sensitive vaccines. Stablepharma is based in Bath, United Kingdom and was founded in 2012. Its last reported valuation was $72.2 million in Dec 2024. It has raised $10.5 million.

Last reported valuation
$72.2M
Oct 2026
Priced at
—
Total raised
$10.5M
Last round
—

Who backs Stablepharma?

10 investors
InvestorType
Innovate UKOther
European Innovation CouncilVenture capital
SFC CapitalVenture capital
AscensionVenture capital
Ascension VenturesFund of funds
Hamilton Investment ManagementHedge fund
Department of Health of UK—
Horizon Europe—
Oval Group—
Passive Income Capital—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Stablepharma investors

10 investors are on record for Stablepharma, including Innovate UK, European Innovation Council, SFC Capital and Ascension. By type, the record holds 3 venture capital firms, 1 hedge fund and 1 fund of funds.

Free account
More of Stablepharma with a free account
  • ·Watch Stablepharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 10 firms already write checks for companies like Stablepharma. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View